BLOG

Is Adipose Stem Cell Therapy Self-Pay in Japan? A Planning Guide

Published 2026.10.17 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are researching regenerative medicine abroad, one of the first practical questions is usually about money and paperwork. Is adipose-derived stem cell therapy covered by insurance in Japan? What should you ask before you book flights? This article explains the general picture so that you can arrive at a consultation with better questions. It is educational information, not medical advice, and it cannot replace an assessment by a physician.

The short answer: it is generally self-pay

At Grand Green Osaka Umekita Clinic, adipose-derived stem cell therapy is offered as a self-pay (not covered by public health insurance) treatment. In Japan, public insurance generally covers treatments whose use for a specific condition has been reviewed and approved through the national system. Many regenerative treatments using a patient’s own cells are provided outside that framework, which is why patients pay for them directly.

Self-pay does not mean unregulated. In Japan, regenerative medicine of this kind is provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be reviewed and submitted to the authorities. Self-pay also does not tell you anything about how well a treatment will work for you. Whether it is suitable, what it may involve, and what the risks and side effects are must be confirmed with a doctor during a consultation.

What the treatment involves, and why that affects planning

The treatment uses mesenchymal stem cells taken from a very small amount of your own fat tissue. The cells are cultured and expanded at a specialized facility and later returned to your body by intravenous infusion. Because collection, culture and infusion happen at different points in time, the process is not a single-day event. Patients who live overseas should therefore ask how the schedule is structured and how many visits to Japan may be needed.

The cell culture step is one reason costs are usually discussed in terms of a whole treatment plan rather than a single procedure. When you ask about fees, it helps to ask exactly which steps are included and which are not, so you can compare information on a like-for-like basis. The clinic’s treatment page and fee page are the right places to check current information, and the doctor can explain how they apply to your situation.

Questions to ask about costs before you commit

Clear answers on cost are part of informed consent. Consider asking the following questions during a consultation or in writing beforehand:

Which steps are covered by the quoted fee, such as the consultation, tests, fat collection, culture and infusion?
Are there separate charges for pre-treatment examinations or blood tests?
What happens to the plan, and to any payment, if the doctor decides treatment is not suitable?
What happens if cells cannot be cultured as planned, or if a visit needs to be rescheduled?
Are there costs for follow-up appointments or for managing any side effects?
Which payment methods are accepted, and in which currency is the fee quoted?

Please note that we do not list prices in this article. Fees can change, and the figure that applies to you should always come from the clinic directly and in writing.

Insurance, reimbursement and travel coverage

Because the treatment is self-pay, you should not assume that Japan’s public health insurance will contribute, even if you live in Japan and are enrolled. Overseas patients should also not assume that their home insurer or a travel insurance policy will reimburse the cost. Policies differ widely, and many exclude treatments that are not part of standard care or that are received abroad for the purpose of treatment.

If reimbursement matters to you, contact your insurer before travelling and ask in plain terms whether this kind of regenerative treatment, provided as self-pay in Japan, could be eligible. Keep their answer in writing. You may also wish to ask whether complications arising from treatment abroad would be covered, since this is a separate question from the cost of treatment itself.

Preparing your medical records and language needs

Good records help a physician judge whether regenerative treatment is even worth discussing. Consider gathering a summary of your diagnosis and current medications, recent imaging or test results, a list of allergies and past surgeries, and the names of the doctors currently treating you. If your records are not in English or Japanese, ask the clinic in advance how it prefers to receive them.

It is also reasonable to tell your regular doctor at home that you are considering this option. Stem cell therapy is not a replacement for standard treatment, and your home physician may be able to advise on timing, ongoing care and follow-up after you return. Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, and it provides an information page for international patients so that you can review language support and the consultation flow before you decide to visit.

A balanced way to decide

Research on mesenchymal stem cells, including cells from adipose tissue, is active and growing, but results vary by condition and study design, and the evidence is still developing. No single study should be treated as proof that a treatment will work for you. Responses differ between individuals, and any treatment carries potential risks and side effects that your doctor should explain.

A practical approach is to separate three questions: whether the treatment suits your medical situation, whether the plan and fees are clear and written down, and whether you can manage the travel and follow-up. Take your time with each one, and feel free to seek a second opinion. If you would like to learn more, you can review the treatment page and fee information, then book a consultation so that a doctor can discuss your individual circumstances, the risks and side effects, and the costs with you in person.

Planning Self-Pay Stem Cell Care

Self-pay careNot covered by public insurance
Ask about feesGet what is included in writing
Prepare recordsDiagnosis, tests, medications
See a doctorConfirm risks and suitability

This figure is a conceptual summary of the article content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›